7-methoxytacrine-4-pyridinealdoxime (7-MEOTA-4-PA, named hybrid 5C) is a compound formerly synthesized and evaluated in vitro, together with 4-pyridine aldoxime (4-PA) and commercial reactivators of acetylcholinesterase (AChE). This compound was designed with the purpose of being a prophylactic reactivator, capable of interacting with different subdomains of the active site of AChE. To investigate these interactions, theoretical results from docking were first compared with experimental data of hybrid 5C, 4-PA, and two commercial oximes, on the reactivation of human AChE (HssAChE) inhibited by VX. Then, further docking studies, molecular dynamics simulations, and molecular mechanics Poisson-Boltzmann surface area calculations, were carried out to investigate reactivation performances, considering the near attack conformation (NAC) approach, prior to the nucleophilic substitution mechanism. Our results helped to elucidate the interactions of such molecules with the different subdomains of the active site of HssAChE. Additionally, NAC poses of each oxime were suggested for further theoretical studies on the reactivation reaction.

b Faculty of Science Department of Chemistry University of Hradec Kralove Hradec Kralove Czech Republic

b Faculty of Science Department of Chemistry University of Hradec Kralove Hradec Kralove Czech Republic c Laboratory of Molecular Modeling Chemistry Department Federal University of Lavras Lavras Brazil

Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense Department of Chemical Engineering Military Institute of Engineering Rio de Janeiro RJ Brazil

Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense Department of Chemical Engineering Military Institute of Engineering Rio de Janeiro RJ Brazil b Faculty of Science Department of Chemistry University of Hradec Kralove Hradec Kralove Czech Republic

Citace poskytuje Crossref.org